Login / Signup
How can we prevent diarrhea induced by systemic treatments in oncological patients? An evaluation of phase II trials.
Andrea Esposito
Paolo Bossi
Published in:
Expert opinion on emerging drugs (2023)
Keyphrases
</>
phase ii
end stage renal disease
clinical trial
ejection fraction
newly diagnosed
open label
chronic kidney disease
prognostic factors
peritoneal dialysis
prostate cancer
patient reported outcomes
radical prostatectomy
clostridium difficile
irritable bowel syndrome
minimally invasive
patient reported